China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...
Eli Lilly and Company (NYSE: LLY) today announced that the National Medical Products Administration (NMPA) in China has ...
China has approved Eli Lillys Kisunla, marking another milestone in global efforts to address Alzheimers disease. The ...
Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...
Kisunla was first approved in the United States in July 2024, approved in Japan in September 2024 and then in Great Britain in October 2024 "Bringing Alzheimer's disease treatment options to ...
Kisunla was first approved in the United States in July 2024, approved in Japan in September 2024 and then in Great Britain in October 2024 INDIANAPOLIS, Dec. 17, 2024 /PRNewswire/ -- Eli Lilly and ...
China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...
Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of ...
FOX 9 Minneapolis-St. Paul on MSN6d
Minnesotans battling Alzheimer's Disease now getting promising new treatmentFOX 9 caught up with a Minnesota woman undergoing a new Alzheimer’s treatment which is showing promise in slowing cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback